Exelixis Clinical Site #171

Rio de Janeiro, Rio de Janeiro 22793-080

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Prostate Cancer, Prostate Adenocarcinoma

Studies at this site

• Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC — Running, not enrolling